Investor 
Life essentials
Phagos
Ending antibiotic resistance through personalized, adaptive treatment.
Phagos enables personalized and scalable antibacterial treatment for animal farms.
THE NEEDS THEY MEET
- 70% of antibiotics worldwide are consumed by livestock farms.
- Emergence of resistant bacteria: Antibiotic resistance accounts for 10% of global mortality, with 1.3 million direct deaths per year.
- Antibiotic pollution: 70% of antibiotics given to animals are released into the environment in active form.
WHAT CONVINCED US
- An expert team: 12 PhDs in microbiology and a founding team with complementary profiles.
- A large market (€20+ billion) seeking alternatives to antibiotics.
- A unique product: Development of unique expertise and database on phage therapy.
Life essentials
CardioParc
Develop a model for high-quality, accessible local cardiology care for everyone, everywhere.
Life essentials
Deuxiemeavis.fr
Democratizing access to medical expertise and maximizing the chances of recovery for patients affected by serious illnesses.
Life essentials
Exits
R-Pur
Fight pollution with the world's most effective masks.
Life essentials
Exits
Télégrafik
Contribute to healthy aging by helping older adults remain independent and providing caregivers with reassurance through remote monitoring.
Life essentials
Ipso Santé
Rethinking the local healthcare system to make it accessible to all.
